<?xml version="1.0" encoding="utf-8"?>
<XML>
    <JOURNAL>
        <YEAR>2026</YEAR>
        <VOL>24</VOL>
        <NO>1</NO>
        <MOSALSAL></MOSALSAL>
        <PAGE_NO>7</PAGE_NO>
        <ARTICLES>
            <ARTICLE>
                <Language_ID>1</Language_ID>
                <TitleE>Comparison of Esophagography and Chest Computed Tomography and the Prognostic Value of Inflammatory Markers for Detecting Anastomotic Leakage After Esophageal Resection</TitleE>
                <URL>https://brieflands.com/journals/amhsr/articles/156851</URL>
                <DOI>10.69107/amh-156851</DOI>
                <DOR></DOR>
                <ABSTRACTS>
                    <ABSTRACT>
                        <Language_ID>1</Language_ID>
                        <CONTENT>Background :Esophageal cancer poses substantial treatment challenges, particularly when esophagectomy is required. Despite advances in multimodality therapy, esophagectomy remains the primary curative approach. Anastomotic leakage (AL) after esophagectomy is associated with mortality rates of up to 40%–60%. Therefore, timely detection and intervention are essential to mitigate adverse outcomes. Objectives :This study aimed to identify the gold standard for assessing AL after esophageal resection. Methods :This prospective study was conducted at Imam Khomeini Complex Hospital, Tehran, Iran. From May to December 2022, a total of 46 patients who underwent esophageal or gastric resection for cancer were enrolled. Patients were evaluated using esophagography, chest computed tomography (CT), C-reactive protein (CRP) levels on postoperative days (within 30 days, as the gold standard of care), and clinical signs. Thirty patients underwent postoperative radiographic examination using a water-soluble contrast medium, and 16 underwent chest CT with oral and intravenous contrast medium during the same period. CRP levels were measured in all patients on the day of esophagography or chest CT. Results :Ten patients exhibited clinical signs of leakage. Among the 30 patients who underwent radiographic examination, 27 (90%) had normal findings and 3 (10%) had AL, whereas clinical signs of AL were present in 10 patients (33.3%). Among the 16 patients who underwent chest CT, 9 (56.3%) had normal findings and 7 (43.8%) had AL. The sensitivity, specificity, and accuracy of radiographic examination were 30%, 100%, and 71.43%, respectively, compared with 71.43%, 66.67%, and 68.75%, respectively, for chest CT. The chi-square test showed no association between CRP levels and clinical signs of leakage (P = 0.771). Conclusions :Esophagography demonstrated lower sensitivity than CT, although its accuracy was higher, indicating that both methods can be used to evaluate patients with clinical signs of AL. C-reactive protein levels were not associated with AL.</CONTENT>
                    </ABSTRACT>
                </ABSTRACTS>
                <PAGES>
                    <PAGE>
                        <FPAGE>1</FPAGE>
                        <TPAGE>7</TPAGE>
                    </PAGE>
                </PAGES>
                <AUTHORS>
                    <AUTHOR>
                        <NameE>Seyed Hosein</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Mirjavadi</FamilyE>
                        <Organizations>
                            <Organization>Department of Cancer Radiology, Imam Khomeini Complex Hospital, Tehran University of Medical Scinece, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>mirjavadihosein@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Mohadese</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Estaji</FamilyE>
                        <Organizations>
                            <Organization>Department of Medical Physics and Biomedical, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>mestaji@yahoo.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Soheila</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Koopaee</FamilyE>
                        <Organizations>
                            <Organization>Department of Cancer Radiology, Imam Khomeini Complex Hospital, Tehran University of Medical Scinece, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>skoopaee@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Farideh</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Pak</FamilyE>
                        <Organizations>
                            <Organization>Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, California, USA</Organization>
                        </Organizations>
                        <Countries>
                            <Country>USA</Country>
                        </Countries>
                        <EMAILS>
                            <Email>farideh.pak@cshs.org</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Amirmohsen</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Jalaeefar</FamilyE>
                        <Organizations>
                            <Organization>Department of Surgical Oncology, Imam Khomeini Complex Hospital, Tehran University of Medical Sciences, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>jalaeefar@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Elahe</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Jazayeri Gharehbagh</FamilyE>
                        <Organizations>
                            <Organization>Department of Radiation Twchnology, Faculty of Allied Medicine, Tehran University of Medical Science, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>ejazayeri@sina.tums.ac.ir</Email>
                        </EMAILS>
                    </AUTHOR>
                </AUTHORS>
                <KEYWORDS>
                    <KEYWORD>
                        <KeyText>No Keyword</KeyText>
                    </KEYWORD>
                </KEYWORDS>
                <PDFFileName>1.pdf</PDFFileName>
                <REFRENCES>
                    <REFRENCE>
                        <REF>[0]Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International journal of cancer. 2019;144(8):1941-53. [PubMed ID: 30350310]. [PubMed Central ID: PMC8791452]. doi: 10.1002/ijc.31937.##[1]Schmidt HM, Gisbertz SS, Moons J, Rouvelas I, Kauppi J, Brown A, et al.Defining benchmarks for transthoracic esophagectomy: a multicenter analysis of total minimally invasive esophagectomy in low risk patients. Annals of surgery. 2017;266(5):814-21. [PubMed ID: 28796646]. doi: 10.1097/SLA.0000000000002445.##[2]Sauvanet A, Baltar J, Le Mee J, Belghiti J.Diagnosis and conservative management of intrathoracic leakage after oesophagectomy. British journal of surgery. 1998;85(10):1446-9. [PubMed ID: 9782035]. doi: 10.1046/j.1365-2168.1998.00869.x.##[3]Kassis ES, Kosinski AS, Ross P, Koppes KE, Donahue JM, Daniel VC.Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. The Annals of thoracic surgery. 2013;96(6):1919-26. [PubMed ID: 24075499]. doi: 10.1016/j.athoracsur.2013.07.119.##[4]Alanezi K, Urschel JD.Mortality secondary to esophageal anastomotic leak. Ann Thorac Cardiovasc Surg. 2004;10(2):71-75. [PubMed ID: 15209546].##[5]Upponi S, Ganeshan A, D'costa H, Betts M, Maynard N, Bungay H, et al.Radiological detection of post-oesophagectomy anastomotic leak-a comparison between multidetector CT and fluoroscopy. The British Journal of Radiology. 2008;81(967):545-8. [PubMed ID: 18559902]. doi: 10.1259/bjr/30515892.##[6]Backer CL, LoCicero J, Hartz RS, Donaldson JS, Shields T.Computed tomography in patients with esophageal perforation. Chest. 1990;98(5):1078-80. [PubMed ID: 2225947]. doi: 10.1378/chest.98.5.1078.##[7]Lantos JE, Levine MS, Rubesin SE, Lau CT, Torigian DA.Comparison between esophagography and chest computed tomography for evaluation of leaks after esophagectomy and gastric pull-through. Journal of Thoracic Imaging. 2013;28(2):121-8. [PubMed ID: 23059739]. doi: 10.1097/RTI.0b013e31826ff062.##[8]Fadoo F, Ruiz DE, Dawn SK, Webb WR, Gotway MB.Helical CT esophagography for the evaluation of suspected esophageal perforation or rupture. American Journal of Roentgenology. 2004;182(5):1177-9. [PubMed ID: 15100114]. doi: 10.2214/ajr.182.5.1821177.##[9]Du Clos TW.Function of C-reactive protein. Annals of medicine. 2000;32(4):274-8. [PubMed ID: 10852144]. doi: 10.3109/07853890009011772.##[10]Pepys MB, Hirschfield GM.C-reactive protein: a critical update. The Journal of clinical investigation. 2003;111(12):1805-12. doi: 10.1172/JCI200318921.##[11]Garcia-Granero A, Frasson M, Flor-Lorente B, Blanco F, Puga R, Carratalá A, et al.Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Diseases of the colon &amp; rectum. 2013;56(4):475-83. [PubMed ID: 23478615]. doi: 10.1097/DCR.0b013e31826ce825.##[12]Lagoutte N, Facy O, Ravoire A, Chalumeau C, Jonval L, Rat P, et al.C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: pilot study in 100 patients. Journal of visceral surgery. 2012;149(5):e345-e9. [PubMed ID: 23102916]. doi: 10.1016/j.jviscsurg.2012.09.003.##[13]Ortega-Deballon P, Facy O, Binquet C.C-reactive protein and procalcitonin as predictors of anastomotic leak. Diseases of the Colon &amp; Rectum. 2013;56(10). e395. [PubMed ID: 24022538]. doi: 10.1097/DCR.0b013e31829eb9a7.##[14]Bracale U, Peltrini R, De Luca M, Ilardi M, Di Nuzzo MM, Sartori A, et al.Predictive factors for anastomotic leakage after laparoscopic and open total gastrectomy: a systematic review. Journal of Clinical Medicine. 2022;11(17):5022. [PubMed ID: 36078954]. [PubMed Central ID: PMC9457286]. doi: 10.3390/jcm11175022.##[15]McOwan M, Johnson MA, Ward S, Read M, Chong L, Taylor L, et al.C-reactive protein is a predictor of severe infective complications following gastrectomy-a retrospective analysis. Journal of Gastrointestinal Oncology. 2022;14(1):64-72. [PubMed ID: 36915451]. [PubMed Central ID: PMC10007915]. doi: 10.21037/jgo-22-675.##[16]Solomon DG, Sasaki CT, Salem RR.An evaluation of the routine use of contrast radiography as a screening test for cervical anastomotic integrity after esophagectomy. The American journal of surgery. 2012;203(4):467-71. [PubMed ID: 21906717]. doi: 10.1016/j.amjsurg.2011.04.005.##[17]Jones CM, Heah R, Clarke B, Griffiths EA.Should routine radiological assessment of anastomotic integrity be performed after oesophagectomy with cervical anastomosis? Best evidence topic (BET). International Journal of Surgery. 2015;15:90-4. [PubMed ID: 25667064]. doi: 10.1016/j.ijsu.2015.01.034.##[18]Markar SR, Arya S, Karthikesalingam A, Hanna GB.Technical factors that affect anastomotic integrity following esophagectomy: systematic review and meta-analysis. Annals of surgical oncology. 2013;20(13):4274-81. [PubMed ID: 23943033]. doi: 10.1245/s10434-013-3189-x.##[19]Fabbi M, Hagens ERC, van Berge Henegouwen MI, Gisbertz SS.Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment. Diseases of the Esophagus. 2021;34(1). doaa039. [PubMed ID: 32476017]. [PubMed Central ID: PMC7801633]. doi: 10.1093/dote/doaa039.##[20]Mejía-Rivera S, Pérez-Marroquín SA, Cortés-González R, Medina-Franco H.Contrast-enhanced swallow study sensitivity for anastomotic leak detection in post-esophagectomy patients. Revista de Gastroenterología de México (English Edition). 2018;83(4):400-4. doi: 10.1016/j.rgmxen.2018.05.006.##[21]Boone J, Rinkes IB, Van Leeuwen M, Van Hillegersberg R.Diagnostic value of routine aqueous contrast swallow examination after oesophagectomy for detecting leakage of the cervical oesophagogastric anastomosis. ANZ Journal of Surgery. 2008;78(9):784-90. [PubMed ID: 18844909]. doi: 10.1111/j.1445-2197.2008.04650.x.##[22]Page RD, Asmat A, McShane J, Russell GN, Pennefather SH.Routine endoscopy to detect anastomotic leakage after esophagectomy. The Annals of Thoracic Surgery. 2013;95(1):292-8. [PubMed ID: 23200235]. doi: 10.1016/j.athoracsur.2012.09.048.##[23]Hu Z, Wang X, An X, Li W, Feng Y, You Z.The diagnostic value of routine contrast esophagram in anastomotic leaks after esophagectomy. World Journal of Surgery. 2017;41(8):2062-7. [PubMed ID: 28255626]. doi: 10.1007/s00268-017-3923-9.##[24]Kim TH, Kim JH, Shin CI, Kim SH, Han JK, Choi BI.CT findings suggesting anastomotic leak and predicting the recovery period following gastric surgery. European Radiology. 2015;25(7):1958-66. [PubMed ID: 25708962]. doi: 10.1007/s00330-015-3608-4.##[25]Gans SL, Atema JJ, van Dieren S, Koerkamp BG, Boermeester MA.Diagnostic value of C-reactive protein to rule out infectious complications after major abdominal surgery: a systematic review and meta-analysis. International journal of colorectal disease. 2015;30(7):861-73. [PubMed ID: 25935447]. [PubMed Central ID: PMC4471323]. doi: 10.1007/s00384-015-2205-y.##[26]Liesenfeld LF, Sauer P, Diener MK, Hinz U, Schmidt T, Müller-Stich BP, et al.Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection. BMC surgery. 2020;20(1). 324. [PubMed ID: 33298038]. [PubMed Central ID: PMC7726907]. doi: 10.1186/s12893-020-00995-2.##[27]Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC.Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg. 2011;35(5):1017-1025. [PubMed ID: 21167776]. doi: 10.1007/s00268-011-1002-1.##[28]Gordon AC, Cross AJ, Foo EW, Roberts RH.C-reactive protein is a useful negative predictor of anastomotic leak in oesophago-gastric resection. ANZ journal of surgery. 2018;88(3):223-7. [PubMed ID: 27457697]. doi: 10.1111/ans.13681.##[29]Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, et al.Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. Journal of Gastrointestinal Surgery. 2012;16(6):1083-95. [PubMed ID: 22419007]. doi: 10.1007/s11605-012-1867-9.##</REF>
                    </REFRENCE>
                </REFRENCES>
            </ARTICLE>
        </ARTICLES>
    </JOURNAL>
</XML>